Doctors at Stanford Cancer Center actively research advanced imaging technologies that improve the diagnosis of neuroendocrine tumors and help track the effectiveness of treatment. Stanford NET specialists invented cutting-edge diagnostic methods and are leaders in researching new treatments for neuroendocrine tumors. Stanford offers multidisciplinary treatment for neuroendocrine tumors in the gastrointestinal tract, lungs, and adrenal glands.
Neurorendocrine Tumor Reseach Foundation collaborates w ith Stanford on a regular basis to offer patient and caregiver conferences in the San Francisco Bay Area. You can view videos of a recent conference and see members of the treatment team present.
Featured Stanford physicians
NETRF awarded six new research grants totaling $1.85 million to leading academic institutions around the world. The goal of the funding is to improve current treatments for neuroendocrine tumors (NETs), an uncommon and poorly understood cancer, which occurs in the body’s hormone-producing cells.